HF1269 (Legislative Session 94 (2025-2026))

Coverage of medical services and prescription medications for the treatment of dementia required, and step therapy requirements for medical assistance modified.

Related bill: SF1998

AI Generated Summary

Purpose

  • Require health plan companies to cover all FDA-approved medical services and prescription medications used to treat or slow the progression of dementia.
  • Require coverage for diagnostic testing to determine whether a medical service or medication is appropriate or effective for treating or slowing dementia.
  • Prohibit the use of step therapy protocols when providing this dementia coverage.

Main Provisions

  • Coverage scope: Health plans must cover every FDA-approved medical service and prescription medication used to treat or slow dementia, as well as related diagnostic tests to assess appropriateness or effectiveness.
  • Step therapy ban: Health plans may not apply step therapy (a process that requires trying less expensive or fewer-risk options before more costly or newer treatments) for the dementia-related services and medications described.
  • Legal amendments: Makes changes to Minnesota Statutes, including amending section 256B.0625 subdivision 13f and adding new provisions in Minnesota Statutes chapter 62Q (specifically 62Q.546).

Significant Changes to Existing Law

  • Broadens required coverage for dementia care by mandating FDA-approved treatments and associated diagnostic testing.
  • Restricts the use of step therapy for dementia treatments, limiting insurers’ ability to delay or deny access to dementia therapies.
  • Introduces a new statutory provision (62Q.546) to codify these dementia coverage requirements and related protections.

Potential Impacts and Considerations

  • Access: Aims to reduce barriers to dementia treatment by ensuring comprehensive coverage and timely access to therapeutics and diagnostics.
  • Costs: May affect premium levels and insurer budgeting due to broader coverage requirements.
  • Scope: Applies to dementia treatments approved by the FDA; does not mention non-FDA-approved or experimental therapies.

Relevant Terms dementia, FDA-approved, medical services, prescription medications, diagnostic testing, coverage, health plan company, step therapy, step therapy protocol, 62Q.184 subdivision 1, 62Q.546, Minnesota Statutes, 256B.0625 subdivision 13f, medical assistance

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
February 20, 2025HouseActionIntroduction and first reading, referred toCommerce Finance and Policy
February 24, 2025HouseActionAuthor added
February 26, 2025HouseActionAuthor added
March 05, 2025HouseActionAuthor added
March 06, 2025HouseActionAuthors added
March 12, 2025HouseActionAuthor added
March 13, 2025HouseActionAuthor added
March 17, 2025HouseActionAuthor added
April 01, 2025HouseActionAuthor added
March 12, 2026HouseActionAuthors added
March 16, 2026HouseActionAuthor added
March 18, 2026HouseActionAuthors added

Citations

 
[
  {
    "analysis": {
      "added": [
        "Adds requirements that health plans cover dementia-related medical services and FDA-approved prescription medications used to treat or slow progression of dementia.",
        "Requires coverage of diagnostic testing to determine the appropriateness or effectiveness of dementia-related medical services or medications."
      ],
      "removed": [],
      "summary": "This bill amends Minnesota Statutes 2024 section 256B.0625, subdivision 13f, to require health plans/medical assistance coverage for dementia-related medical services and FDA-approved medications, and to ensure diagnostic testing is covered to assess treatment appropriateness or effectiveness.",
      "modified": [
        "Incorporates a prohibition on the use of step therapy for dementia coverage by referencing 62Q.184, subdivision 1."
      ]
    },
    "citation": "256B.0625",
    "subdivision": "13f"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "Defines the step therapy protocol in 62Q.184, subdivision 1, which the bill references to prohibit its use in dementia coverage.",
      "modified": [
        "Applied to dementia coverage by prohibiting the use of the defined step therapy when providing dementia-related coverage."
      ]
    },
    "citation": "62Q.184",
    "subdivision": "1"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "References Minnesota Statutes chapter 62Q as the governing chapter for the bill's step therapy provisions related to dementia coverage.",
      "modified": []
    },
    "citation": "62Q",
    "subdivision": ""
  }
]
Loading…